New evidence for the effect of type 2 diabetes and glycemic traits on testosterone levels: a two-sample Mendelian randomization study

Bibliographic Details
Title: New evidence for the effect of type 2 diabetes and glycemic traits on testosterone levels: a two-sample Mendelian randomization study
Authors: Chengyang Jiang, Yuwei Wang, Wenqiang Yang, Xinghai Yang
Source: Frontiers in Endocrinology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Diseases of the endocrine glands. Clinical endocrinology
Subject Terms: Mendelian randomization, testosterone, diabetes, glycemic traits, sexual dysfunction, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
More Details: ObjectiveType 2 diabetes mellitus (T2DM) is an endocrine-related disease with an increasing incidence worldwide. Male sexual dysfunction is common in diabetic patients. Therefore, we designed a Mendelian randomization (MR) study to investigate the association of type 2 diabetes and 3 glycemic traits with testosterone levels.MethodsUncorrelated single nucleotide polymorphisms (SNPs) associated with T2DM (N = 228), fasting insulin (N = 38), fasting glucose (N = 71), and HbA1c (N = 75) at the genome-wide significance were selected as instrument variables. Genetic associations with testosterone levels (total testosterone, TT, bioavailable testosterone, BT, and sex hormone-binding globulin, SHBG) were obtained from the UK Biobank studies and other large consortia. Two-sample MR analysis was used to minimize the bias caused by confounding factors and response causality. Multivariable MR analysis was performed using Body mass index (BMI), Triglycerides (TG), LDL cholesterol (LDL), and adiponectin to adjust for the effects of potential confounders.ResultsType 2 diabetes mellitus was associated with the decrease of total testosterone (β: -0.021,95%CI: -0.032, -0.010, p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-2392
Relation: https://www.frontiersin.org/articles/10.3389/fendo.2023.1238090/full; https://doaj.org/toc/1664-2392
DOI: 10.3389/fendo.2023.1238090
Access URL: https://doaj.org/article/e42bfea2d9b041caa9f6c026e10cfe56
Accession Number: edsdoj.42bfea2d9b041caa9f6c026e10cfe56
Database: Directory of Open Access Journals
More Details
ISSN:16642392
DOI:10.3389/fendo.2023.1238090
Published in:Frontiers in Endocrinology
Language:English